Stay informed with the latest litigation news. Explore now

Surface Oncology patent opposition analysis

Explore patent oppositions filed by Surface Oncology against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 21, 2021
Anti-Pvrig Antibodies And Methods Of UseCOMPUGENOct 28, 2020

Top competitors of Surface Oncology

Top competitors of Surface Oncology based on patent oppositions.